J B Chemicals & Pharmaceuticals Ltd.
|
Income Statement
|
|
You can view the
Income Statement
for the last 5 years.
Market Cap. (Rs.)
|
28603.63 Cr.
|
P/BV
|
11.53
|
Book Value (Rs.)
|
159.82
|
52 Week High/Low (Rs.)
|
1940/875
|
FV/ML
|
1/1
|
P/E(X)
|
51.76
|
Bookclosure
|
16/02/2024
|
EPS (Rs.)
|
35.61
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 3120.91 | 2397.62 | 2002.11 | 1740.60 | 1606.75 |
Other Operating Revenues | 28.37 | 26.63 | 40.41 | 34.13 | 36.45 |
Total Operating Revenues | 3149.28 | 2424.24 | 2042.52 | 1774.73 | 1643.20 |
| | | | | |
Other Income | 9.94 | 39.23 | 112.38 | 50.67 | 41.44 |
Total Revenue | 3159.22 | 2463.47 | 2154.90 | 1825.40 | 1684.64 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 783.98 | 602.22 | 542.39 | 452.48 | 453.75 |
Purchase Of Stock-In Trade | 395.22 | 258.16 | 200.37 | 182.31 | 162.10 |
Changes In Inventories Of FG,WIP And Stock-In Trade | -11.00 | -17.45 | -41.26 | -3.99 | -19.30 |
Employee Benefit Expenses | 543.45 | 439.24 | 340.60 | 322.92 | 288.18 |
Finance Costs | 36.05 | 5.12 | 7.24 | 3.03 | 4.20 |
Depreciation And Amortisation Expenses | 114.41 | 72.66 | 68.67 | 66.32 | 55.64 |
Other Expenses | 741.88 | 598.61 | 440.01 | 443.44 | 453.08 |
Total Expenses | 2603.99 | 1958.57 | 1558.02 | 1466.51 | 1397.65 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 555.23 | 504.90 | 596.89 | 358.89 | 286.99 |
| | | | | |
Exceptional Items | 0.00 | 0.00 | 0.00 | -10.00 | 0.00 |
Profit/Loss Before Tax | 555.23 | 504.90 | 596.89 | 348.89 | 286.99 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 89.31 | 128.15 | 142.20 | 84.69 | 78.46 |
Deferred Tax | 55.92 | -9.29 | 6.16 | -7.89 | 13.64 |
Tax For Earlier Years | 0.00 | 0.00 | 0.00 | -0.30 | 0.92 |
Total Tax Expenses | 145.23 | 118.86 | 148.36 | 76.50 | 93.02 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 410.01 | 386.04 | 448.52 | 272.39 | 193.97 |
| | | | | |
Profit/Loss From Continuing Operations | 410.01 | 386.04 | 448.52 | 272.39 | 193.97 |
| | | | | |
Profit/Loss For The Period | 410.01 | 386.04 | 448.52 | 272.39 | 193.97 |
| | | | | |
Minority Interest | -0.17 | -0.68 | -0.56 | -0.35 | -0.50 |
Consolidated Profit/Loss After MI And Associates | 409.84 | 385.36 | 447.96 | 272.05 | 193.47 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 53.00 | 49.86 | 57.96 | 34.20 | 23.54 |
Diluted EPS (Rs.) | 52.34 | 49.86 | 57.96 | 34.20 | 23.54 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 127.59 | 127.52 | 73.42 | 141.53 | 20.15 |